BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22748132)

  • 1. Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology.
    Khelaifia S; Drancourt M
    Clin Microbiol Infect; 2012 Sep; 18(9):841-8. PubMed ID: 22748132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobicity of imidazole derivatives correlates with improved activity against human methanogenic archaea.
    Khelaifia S; Brunel JM; Raoult D; Drancourt M
    Int J Antimicrob Agents; 2013 Jun; 41(6):544-7. PubMed ID: 23561316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antimicrobial resistance pattern of cultured human methanogens reflects the unique phylogenetic position of archaea.
    Dridi B; Fardeau ML; Ollivier B; Raoult D; Drancourt M
    J Antimicrob Chemother; 2011 Sep; 66(9):2038-44. PubMed ID: 21680581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102).
    Biedenbach DJ; Rhomberg PR; Mendes RE; Jones RN
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):301-7. PubMed ID: 20159376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of new antimicrobial agents on the ecological balance of human microflora.
    Rashid MU; Weintraub A; Nord CE
    Anaerobe; 2012 Apr; 18(2):249-53. PubMed ID: 22155131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Archaea--the significant inhabitants of human microbiome].
    Efenberger M; Wódz K; Brzezińska-Błaszczyk E
    Przegl Lek; 2014; 71(6):346-51. PubMed ID: 25344977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Neisseria gonorrhoeae to antimicrobial peptides from amphibian skin, dermaseptin, and derivatives.
    Zairi A; Tangy F; Ducos-Galand M; Alonso JM; Hani K
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):319-24. PubMed ID: 17254733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel deoxyribofuranosyl indole antimicrobial agents.
    Paudel A; Hamamoto H; Kobayashi Y; Yokoshima S; Fukuyama T; Sekimizu K
    J Antibiot (Tokyo); 2012 Feb; 65(2):53-7. PubMed ID: 22167161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
    Hernández García AM; Arias A; Felipe A; Alvarez R; Sierra A
    Microbiologia; 1995 Dec; 11(4):485-90. PubMed ID: 8588844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on comparative mechanistic studies of antimicrobial peptides against archaea.
    Varnava KG; Ronimus RS; Sarojini V
    Biotechnol Bioeng; 2017 Nov; 114(11):2457-2473. PubMed ID: 28734066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options in an era of decreasing antimicrobial susceptibility.
    Drlica K; Schmitz FJ
    J Chemother; 2002 Feb; 14 Suppl 2():5-12. PubMed ID: 12003139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical limitations of in vitro testing of microorganism susceptibility.
    Nightingale J
    Am J Hosp Pharm; 1987 Jan; 44(1):131-7. PubMed ID: 3826085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory tools for detection of archaea in humans.
    Dridi B
    Clin Microbiol Infect; 2012 Sep; 18(9):825-33. PubMed ID: 22897827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007.
    Hoban DJ; Bouchillon SK; Hawser SP; Badal RE
    Diagn Microbiol Infect Dis; 2010 Jan; 66(1):78-86. PubMed ID: 19733993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial susceptibility in vitro of 32 drugs against pig Streptococcus isolates in China].
    Wang LP; Lu CP; Tang JQ
    Wei Sheng Wu Xue Bao; 2004 Dec; 44(6):794-9. PubMed ID: 16110963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hansch analysis of veratric acid derivatives as antimicrobial agents.
    Narasimhan B; Ohlan S; Ohlan R; Judge V; Narang R
    Eur J Med Chem; 2009 Feb; 44(2):689-700. PubMed ID: 18597896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
    Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
    Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents.
    Koeth LM; Good CE; Appelbaum PC; Goldstein EJ; Rodloff AC; Claros M; Dubreuil LJ
    J Antimicrob Chemother; 2004 Jun; 53(6):1039-44. PubMed ID: 15128729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro archaeacidal activity of biocides against human-associated archaea.
    Khelaifia S; Brunel JM; Drancourt M
    PLoS One; 2013; 8(5):e62738. PubMed ID: 23658767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.